Metraipolis › archive › dc_3832094fc662

Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome — Europe PMC PMID:41578514

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41578514
DOI
10.1097/md.0000000000046998
License (as archived)
solo-consultazione
Archived
2026-11-07T05:06:44.943Z
SHA-256 of the archived text
b14f39f3c3ec10991b6efd1c19aead106f241faee94f92d8e596088d5822ad73
Stable URL of this page
https://metraipolis.com/documento/dc_3832094fc662

How to cite

Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome — Europe PMC PMID:41578514 — Europe PMC (en), https://europepmc.org/article/MED/41578514 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3832094fc662 (Metraipolis archive dc_3832094fc662, sha256 b14f39f3c3ec10991b6efd1c19aead106f241faee94f92d8e596088d5822ad73)
BibTeX
@misc{dc3832094fc662,
  title = {Furmonertinib in lung adenocarcinoma with EGFR exon 20 insertion mutation: A case report of positive outcome — Europe PMC PMID:41578514},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41578514},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3832094fc662; sha256 b14f39f3c3ec10991b6efd1c19aead106f241faee94f92d8e596088d5822ad73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41578514. Agents can read the archived copy with the MCP tool read_document.